MOMO'S BREAKOUT BOARD

[Truenorth2016]

$$ENZC$$: MONOCLONAL ANTIBODY PIONEER & INNOVATOR MR. CHARLES COTROPIA IS NOW ON ENZC BOARD AND HE IS THE CEO OF ENZC MERGER PARTNER BIOCLONETICS!!!

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158692165

THIS 2013 Article Confirms ENZC, MR. CHARLES COTROPIA IS THE PIONEER AND INNOVATOR OF A MONOCLONAL ANTIBODY AND PATENTED HIS DISCOVERY IN 1989 WAY BEFORE THIS COVID EPIDEMIC!!! ENZC GOING TO DOLLARS FOR REAL!!!

https://aumag.org/2013/09/26/the-future-of-clone-3/ (<<<<<<<-------ARTICLE VALIDATES MR. CHARLES COTROPIA AS A DISCOVERER, PIONEER & INNOVATOR OR A MONOCLONAL ANTIBODY)

After many years of research, Cotropia had discovered a human monoclonal antibody that has a powerful potential for neutralizing HIV strains in a vaccine.

To put it simply, Cotropia discovered a human cell line producing a specific human antibody that targets a genetic sequence designated KLIC on the surface of HIV’s outer envelope. Dr. Cotropia named it Clone 3. This antibody can lock onto the KLIC epitope (the epitope is a key spot on the envelope where the virus is vulnerable to antibody action) in such a way that the virus is unable to reproduce, and ultimately cannot infect a human cell. Cotropia patented his discovery in 1989.